lobbying_activities: 3801620

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3801620	f85b5557-dc26-4b1e-b877-0e174629fd7d	Q1	THE WASHINGTON TAX & PUBLIC POLICY GROUP	294930	ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION	2026	first_quarter	TAX	Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income and the potential impacts on financial reporting and on the tax base of the U.S. and its Territories. Issues related to the taxation of intellectual property income. Issues related to IRC sections 11, 41 and 174, 55, 56A, and 59, 59A, 163(j), 250, 951A.	HOUSE OF REPRESENTATIVES,SENATE	500000		0	0	2026-04-01T12:41:01-04:00